Unveiling Novel Biomarkers: Ferroptosis and m1A in the Progression of Nanographene‐Induced Lung Fibrosis
Small · 2026-01 · 22 (5)
DOI: 10.1002/smll.202508818 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 29.11.2025. Verfasst von Jiarui Xia und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Occupational and Environmental Health, School of Public Health, Zhengzhou University, Zhengzhou, Henan, 450001, P. R. China. Hauptthemen laut MEDLINE: Ferroptosis, Graphite, Pulmonary Fibrosis, Biomarkers. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Graphene, a novel 2D carbon‐based material, has become integral to energy capture and storage facilities in wind and photovoltaic energy. Its widespread application has escalated concerns regarding occupational inhalation exposure, necessitating urgent identification of associated health risks and preventive strategies. Divergent outcomes are reported regarding nanographene‐induced pulmonary fibrosis. Intriguingly, multiple modes of programmed cell death, including ferroptosis, are discovered to have essential regulatory roles in the pathological process. Nevertheless, their relationship with graphene exposure and the resulting toxic effects remains unexplored. In this study, it is demonstrated that escalating graphene exposure durations and doses induced tissue‐specific organ damage, predominantly localized to the pulmonary and immune systems. Notably, cellular ferroptosis is accompanied by lung tissue fibrosis, a finding further confirmed by metabolomics. Furthermore, 1‐methyladenosine is identified as a responsive biomarker of graphene exposure, with functional validation implicating tRNA methyltransferase 6 (TRMT6 and tRNA methyltransferase 61A (TRMT61A). Collectively, the findings suggest that m1A mediates critical signaling during the progression of fibrosis and ferroptosis induced by graphene exposure and can serve as a potential biomarker of graphene exposure. Targeting TRMT6/TRMT61A may offer therapeutic avenues against graphene‐induced toxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Occupational and Environmental Health, School of Public Health, Zhengzhou University, Zhengzhou, Henan, 450001, P. R. China.
- College of Materials Science and Engineering, Zhengzhou University, Zhengzhou, 450052, P. R. China.
- The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450000, P. R. China.
- Henan Key Laboratory of Tumor Epidemiology, Zhengzhou, Henan, 450000, P. R. China.
- Henan International Joint Laboratory of Tumor Biomarkers and Molecular Imaging, Zhengzhou, Henan, 450000, P. R. China.
ORCID-Profile: Jiarui Xia, Youliang Zhao
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Xia, J., Wu, W., Fan, H., Tang, X., Li, S., Tang, K., Hao, C., Xu, Q., Zhao, Y., & Yao, W. (2026). Unveiling Novel Biomarkers: Ferroptosis and m1A in the Progression of Nanographene‐Induced Lung Fibrosis. Small, 22(5). https://doi.org/10.1002/smll.202508818
Vancouver
Xia J, Wu W, Fan H, Tang X, Li S, Tang K, et al. Unveiling Novel Biomarkers: Ferroptosis and m1A in the Progression of Nanographene‐Induced Lung Fibrosis. Small. 2026;22(5). doi:10.1002/smll.202508818
BibTeX
@article{Xia2026,
author = {Xia, Jiarui and Wu, Wenzhuo and Fan, Hui and Tang, Xiaolong and Li, Shuqi and Tang, Ke and Hao, Changfu and Xu, Qun and Zhao, Youliang and Yao, Wu},
title = {Unveiling Novel Biomarkers: Ferroptosis and m1A in the Progression of Nanographene‐Induced Lung Fibrosis},
journal = {Small},
year = {2026},
volume = {22},
number = {5},
doi = {10.1002/smll.202508818}
}
EUVIMED